CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project introduces an innovative cancer screening method using Opto-Magnetic Imaging Spectroscopy, which significantly reduces costs and improves accuracy for detecting cervical, prostate, and colon cancers. The technology aims to enhance early diagnosis and healthcare efficiency.
Cancer is among the leading causes of death in the modern world with over 8 million cancer related deaths globally and over 1 million in the EU.
The estimated economic costs of this EU social problem in 2009 was over €120 billion with the healthcare costs at 40% of this amount.
Early identification of cancers continues as a key priority to reducing loss of life and subsequent treatment costs.
Screening for cervical cancer is very effective at controlling the disease, but the costs for the 32 mi…
TUMOUR TRACE LTD
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
